ClinicalTrials.gg
CompletedNCT04766554COSMICSUpdated Jan 28, 2026

Cerebral Oxygen Saturation Monitoring In Cardiac Surgery (COSMICS)

An interventional study of Cerebral oximetry monitor (The INVOS® Cerebral/Somatic Oximeter) and protocol-based interventions in Cardiac Disease and Cognitive Dysfunction, sponsored by Instituto Nacional de Cardiologia de Laranjeiras. Completed at 2 sites in Brazil. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-01-28.

Sponsored by Instituto Nacional de Cardiologia de Laranjeiras · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
326
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 48 studies in Heart Diseases with a site in Brazil — 11 open to participants now, 12 under way, 3 of them phase 3. Heart Diseases · Brazil.

Enrollment
20th of 44
326 · median 274
Started
2021
with 2 others
No phase
21 of 48
7 open now
Registered
32nd of 48
by date

Among the 48 studies in Heart Diseases with a site in Brazil, this one is the 20th largest by enrollment of the 44 interventional ones that give a count, is one of 3 that started in 2021, is one of 21 with no phase, and was the 32nd registered.

Heart Diseases

2,135 studies on the registry are indexed under Heart Diseases; 250 are open to participants now.

Browse Heart Diseases studies →

Open to participants now

11 of the 48 studies in Heart Diseases with a site in Brazil are open now. Recruiting first, the newest first:

6 more — sign in →

All 11 open studies →

A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →

Who these studies take

Of the 182 Heart Diseases studies recruiting now, 128 (70%) set no upper age limit and 22 (12%) stop at 75 or younger; 33 take children under 18; 41 take healthy volunteers.

This study: 60 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 48 studies in Heart Diseases with a site in Brazil, or all of them as a file.
02

Study summary

Neurological dysfunction continues to be one of the complications of considerable concern in patients undergoing cardiac surgery. It was previously reported in the literature, that cerebral oxygen desaturation during cardiac surgery was associated with an increased incidence of cognitive impairment. This study aims to determine whether continuous monitoring of cerebral oximetry improves the neurocognitive outcome in coronary artery bypass surgery when associated with predetermined intervention protocol to optimize cerebral oxygenation.

Read the detailed description

Despite all the progress over the last decades regarding the improvement of the perioperative care of patients with heart disease and the development of new surgical techniques, neurological dysfunction continues to be one of the complications of the greatest concern in patients undergoing cardiac surgery with cardiopulmonary bypass. Brain injury can manifest itself through permanent or temporary injury, contributing to the increase in-hospital mortality, in the length of stay in intensive care, in the length of hospital stay, to a higher incidence of motor dysfunction requiring rehabilitation, and consequently, to reduced quality of life.

Even though the causes of brain injury are multifactorial, perioperative cerebral hypoperfusion, tissue hypoxia, and thromboembolic events are among the main factors related to neurological dysfunction.

Several clinical studies have indicated an association between cerebral desaturation and the increase of neurological complications. Cerebral oximetry monitoring using near-infrared spectroscopy (NIRS) is a non-invasive technique used to estimate regional cerebral oxygen saturation (rSO2) and has been associated with diminishing the incidence of neurological complications.

There is no consensus in the literature about its real benefit, mainly due to the absence of well-designed scientific studies that demonstrate that cerebral desaturation associated with intervention measures to improve rSO2, are related to the prevention of neurological dysfunction in adult cardiac surgery.

The study hypothesis evaluates whether continuous monitoring of cerebral oximetry improves the neurocognitive outcome in coronary artery bypass surgery when associated with early interventions to optimize rSO2.

03

Conditions studied

  • Cardiac Disease
  • Cognitive Dysfunction

Keywords

  • Intraoperative Neurophysiologic Monitorings
04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 60 or older
  • Elective coronary artery bypass graft surgery using cardiopulmonary bypass
  • Preoperative cognitive assessment by means of (MMSE) test, greater than or equal to 24
  • Signed

Exclusion criteria

Exclusion Criteria:

  • Patients with focal neurologic deficit
  • Carotid artery stenosis greater than 70%
  • Patients with pre-existing cognitive dysfunction
  • Patients with psychotic disorders
  • History of allergy to adhesive part of the electrode
  • History of craniofacial surgery
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
326 participants (actual)

Study arms

  • Active comparator
    Cerebral Oxymetry Monitoring

    The following procedures should be performed sequentially in the event of cerebral desaturation after 30 seconds: 1. The positioning of the head, the presence of facial plethora, and bad position of catheters should be corrected; 2. In case of arterial hypotension, the causal factors should be assessed and treated; 3. In the presence of arterial hypoxemia, the causal factors should be assessed and treated to maintain a PaO2 \> 150 mmHg; 4. In the presence of hypercapnia, adjust the ventilation parameters avoiding hyperventilation; 5. In the presence of anemia, the causal factors should be assessed, and the decision to undergo transfusion should also take into consideration the presence of tissue hypoperfusion; 6. In cases of SvO2 below 70% and signs of hemodynamic instability, optimize fluid replacement and ventricular global contractility; 7. Assess the increase of brain consumption of O2, avoiding the superficial level of anesthesia, hyperthermia, and tremors.

    Device: Cerebral oximetry monitor (The INVOS® Cerebral/Somatic Oximeter) and protocol-based interventions

  • No intervention
    Control Group

    Patients will be treated according to the attending anesthesiologist, without the monitoring of cerebral oximetry, but to maintain a heart rate between 70 - 100 bpm, lactate levels \<3 mmol/L and urine output\> 0.5mL/Kg/h. In case of arterial hypotension the causal factors should be assessed and treated; in case of SvO2 below 70% and signs of hemodynamic instability, optimize volume replacement and global ventricular contractility through inotropic agents (epinephrine, dobutamine or milrinone); in the presence of anemia (Hb \<6 to 7g/dL during CPB or Hb \<8g/dL in the pre-CPB or post-CPB period), the causal factors should be assessed and the decision to transfuse should also take into account the presence of hypoperfusion tissue (increased lactate, low SvO2, acidosis); in episodes of bradycardia with hemodynamic instability, atropine may be used.

Interventions

  • DeviceCerebral oximetry monitor (The INVOS® Cerebral/Somatic Oximeter) and protocol-based interventions

    In the intervention group, an alarm threshold below 15% of the baseline rSO2 value will be established. Based on the predetermined algorithm the rSO2 will be maintained at or above 85% of the baseline measurements. If the rSO2 reaches levels below 15% of the baseline values or below 50% in absolute value for over 30 seconds, protocol-based interventions will be performed to restore rSO2 to baseline levels.

06

What researchers measure

Primary outcomes

  1. Preoperative cognitive function

    Mini Mental State Examination (MMSE)

    Time frame: Pre-surgery (within 10 days before)

  2. Postoperative cognitive dysfunction - delayed cognitive recovery

    Mini Mental State Examination (MMSE)

    Time frame: Post-surgery (7 days after surgery)

  3. Postoperative cognitive dysfunction - neurocognitive disorder

    Mini Mental State Examination (MMSE)

    Time frame: Post-surgery (90 days after surgery)

  4. Preoperative cognitive function II

    Montreal Cognitive Assessment (MoCA) test

    Time frame: Pre-surgery (within 10 days before)

  5. Postoperative cognitive dysfunction - delayed cognitive recovery II

    Montreal Cognitive Assessment (MoCA) test

    Time frame: Post-surgery (7 days after surgery)

  6. Postoperative cognitive dysfunction - neurocognitive disorder II

    Montreal Cognitive Assessment (MoCA) test

    Time frame: Post-surgery (90 days after surgery)

  7. Preoperative cognitive function III

    The Telephone Interview for Cognitive Status (TICS)

    Time frame: Pre-surgery (within 10 days before)

  8. Postoperative cognitive dysfunction - delayed cognitive recovery III

    The Telephone Interview for Cognitive Status (TICS)

    Time frame: Post-surgery (7 days after surgery)

  9. Postoperative cognitive dysfunction - neurocognitive disorder III

    The Telephone Interview for Cognitive Status (TICS)

    Time frame: Post-surgery (90 days after surgery)

Secondary outcomes

  1. Incidence of postoperative delirium

    Delirium will be assessed postoperatively for seven days or until discharge

    Time frame: Delirium assessment CAM-ICU preoperatively (baseline) and postoperatively twice a day during the first seven days or until discharge

  2. Neurological injury type I (stroke)

    The incidence of neurological injury type I will be evaluated for 30 days

    Time frame: Post-surgery (until 30 days after surgery)

  3. Duration of mechanical ventilation

    The duration of mechanical ventilation will be evaluated

    Time frame: Post-surgery (until 30 days after surgery)

  4. Length of stay at the intensive care unit (ICU)

    The length of stay at the intensive care unit (ICU) will be evaluated

    Time frame: Post-surgery (until 30 days after surgery)

  5. Length of stay at the hospital

    The length of stay at the hospital will be evaluated

    Time frame: Post-surgery (until 30 days after surgery)

  6. Incidence of mortality resulting from all causes

    All causes of mortality will be assessed for 30 days

    Time frame: Post-surgery (until 30 days after surgery)

07

Study locations

2 sites
  • Instituto Nacional de Cardiologia
    Rio de Janeiro, Rio de Janeiro, Brazil
  • Hospital São José
    Criciúma, Santa Catarina, Brazil
08

References and documents

Publications

  • Zheng F, Sheinberg R, Yee MS, Ono M, Zheng Y, Hogue CW. Cerebral near-infrared spectroscopy monitoring and neurologic outcomes in adult cardiac surgery patients: a systematic review. Anesth Analg. 2013 Mar;116(3):663-76. doi: 10.1213/ANE.0b013e318277a255. Epub 2012 Dec 24. PubMed 23267000 ↗
  • Deschamps A, Hall R, Grocott H, Mazer CD, Choi PT, Turgeon AF, de Medicis E, Bussieres JS, Hudson C, Syed S, Seal D, Herd S, Lambert J, Denault A, Deschamps A, Mutch A, Turgeon A, Denault A, Todd A, Jerath A, Fayad A, Finnegan B, Kent B, Kennedy B, Cuthbertson BH, Kavanagh B, Warriner B, MacAdams C, Lehmann C, Fudorow C, Hudson C, McCartney C, McIsaac D, Dubois D, Campbell D, Mazer D, Neilpovitz D, Rosen D, Cheng D, Drapeau D, Dillane D, Tran D, Mckeen D, Wijeysundera D, Jacobsohn E, Couture E, de Medicis E, Alam F, Abdallah F, Ralley FE, Chung F, Lellouche F, Dobson G, Germain G, Djaiani G, Gilron I, Hare G, Bryson G, Clarke H, McDonald H, Roman-Smith H, Grocott H, Yang H, Douketis J, Paul J, Beaubien J, Bussieres J, Pridham J, Armstrong JN, Parlow J, Murkin J, Gamble J, Duttchen K, Karkouti K, Turner K, Baghirzada L, Szabo L, Lalu M, Wasowicz M, Bautista M, Jacka M, Murphy M, Schmidt M, Verret M, Perrault MA, Beaudet N, Buckley N, Choi P, MacDougall P, Jones P, Drolet P, Beaulieu P, Taneja R, Martin R, Hall R, George R, Chun R, McMullen S, Beattie S, Sampson S, Choi S, Kowalski S, McCluskey S, Syed S, Boet S, Ramsay T, Saha T, Mutter T, Chowdhury T, Uppal V, Mckay W; Canadian Perioperative Anesthesia Clinical Trials Group. Cerebral Oximetry Monitoring to Maintain Normal Cerebral Oxygen Saturation during High-risk Cardiac Surgery: A Randomized Controlled Feasibility Trial. Anesthesiology. 2016 Apr;124(4):826-36. doi: 10.1097/ALN.0000000000001029. PubMed 26808629 ↗
  • Slater JP, Guarino T, Stack J, Vinod K, Bustami RT, Brown JM 3rd, Rodriguez AL, Magovern CJ, Zaubler T, Freundlich K, Parr GV. Cerebral oxygen desaturation predicts cognitive decline and longer hospital stay after cardiac surgery. Ann Thorac Surg. 2009 Jan;87(1):36-44; discussion 44-5. doi: 10.1016/j.athoracsur.2008.08.070. PubMed 19101265 ↗
  • Lei L, Katznelson R, Fedorko L, Carroll J, Poonawala H, Machina M, Styra R, Rao V, Djaiani G. Cerebral oximetry and postoperative delirium after cardiac surgery: a randomised, controlled trial. Anaesthesia. 2017 Dec;72(12):1456-1466. doi: 10.1111/anae.14056. Epub 2017 Sep 22. PubMed 28940368 ↗
  • Colak Z, Borojevic M, Bogovic A, Ivancan V, Biocina B, Majeric-Kogler V. Influence of intraoperative cerebral oximetry monitoring on neurocognitive function after coronary artery bypass surgery: a randomized, prospective study. Eur J Cardiothorac Surg. 2015 Mar;47(3):447-54. doi: 10.1093/ejcts/ezu193. Epub 2014 May 7. PubMed 24810757 ↗
  • Serraino GF, Murphy GJ. Effects of cerebral near-infrared spectroscopy on the outcome of patients undergoing cardiac surgery: a systematic review of randomised trials. BMJ Open. 2017 Sep 7;7(9):e016613. doi: 10.1136/bmjopen-2017-016613. PubMed 28882917 ↗
  • Murkin JM, Adams SJ, Novick RJ, Quantz M, Bainbridge D, Iglesias I, Cleland A, Schaefer B, Irwin B, Fox S. Monitoring brain oxygen saturation during coronary bypass surgery: a randomized, prospective study. Anesth Analg. 2007 Jan;104(1):51-8. doi: 10.1213/01.ane.0000246814.29362.f4. PubMed 17179242 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2021 to primary completion in Aug 2024, 39 months.

Of 264 non-industry interventional studies with no phase under Heart Diseases, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 51. This study's 39 months is above that.

Counting every sponsor, half of 337 studies reached it within 25 months; a quarter within 11 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 16, 2021
First posted
Feb 23, 2021
StartActual
May 19, 2021
Primary completionActual
Aug 20, 2024
CompletionActual
Aug 20, 2024
Last update
Jan 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04766554
Lead sponsor
Instituto Nacional de Cardiologia de Laranjeiras
Responsible party
Carlos Galhardo Jr. (Chief of Adult Cardiac Anesthesia Division, Instituto Nacional de Cardiologia de Laranjeiras) — Principal investigator
First posted
Feb 23, 2021
Start date
May 19, 2021
Primary completion
Aug 20, 2024
Completion
Aug 20, 2024
Last update
Jan 28, 2026

Study contacts

Carlos Galhardo, MD
principal investigator · Instituto Nacional de Cardiologia

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion